ACRS – aclaris therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Aclaris Therapeutics And 2 Other US Penny Stocks To Watch [Yahoo! Finance]
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating.
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) was upgraded by analysts at Leerink Partnrs from a "hold" rating to a "strong-buy" rating.
Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments [Yahoo! Finance]
ACRS Stock Up on Licensing Deal With Biosion for Two Immunology Drugs [Yahoo! Finance]
Form SC 13G Aclaris Therapeutics, Filed by: Vivo Opportunity Fund Holdings, L.P.
Form 4 Aclaris Therapeutics, For: Nov 19 Filed by: Mehra Anand
Form 3 Aclaris Therapeutics, For: Nov 18 Filed by: Davis Hugh M.
Form 8-K Aclaris Therapeutics, For: Nov 16
Form SC 13G/A Aclaris Therapeutics, Filed by: CITADEL ADVISORS LLC
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.